In conclusion (Fig 9), this study demonstrates that HO-1 induction in the liver reduced fructose-induced hepatic lipid deposition, prevented the development of hepatic fibrosis and abated NAFLD-associated metabolic and vascular imbalance; effects that are mediated by activation of the SIRT1 gene expression. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.